AI assistant
Ocugen, Inc. — Director's Dealing 2019
Dec 5, 2019
32915_dirs_2019-12-05_d890b244-9953-4cd5-98b9-f8447101a42a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-12-04
Reporting Person: Zhang Junge (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-04 | Common Stock | P | 220000 | $.44 | Acquired | 818578 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 212863 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.43 to $0.44. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4.
F2: The amount in Column 5 reflects the deduction of 1,500 shares to correct an error in the reporting person's Forms 4 filed on November 20, 2019, November 26, 2019 and December 2, 2019, in which the number of shares beneficially owned by the reporting person following those dates were over-reported by 1,500 shares.